- Report
- March 2025
- 204 Pages
North America
From €3029EUR$3,450USD£2,649GBP
- Report
- March 2025
- 172 Pages
Middle East, Africa
From €3029EUR$3,450USD£2,649GBP
- Report
- March 2025
- 209 Pages
Europe
From €3029EUR$3,450USD£2,649GBP
- Report
- March 2025
- 198 Pages
Asia Pacific
From €3029EUR$3,450USD£2,649GBP
- Report
- May 2025
- 150 Pages
United States
From €2195EUR$2,500USD£1,920GBP
- Report
- February 2026
- 150 Pages
United States
From €3380EUR$3,850USD£2,956GBP
€4258EUR$4,850USD£3,724GBP
- Report
- February 2026
- 150 Pages
United States
From €3380EUR$3,850USD£2,956GBP
€4258EUR$4,850USD£3,724GBP
- Report
- February 2026
- 170 Pages
United States
From €3380EUR$3,850USD£2,956GBP
€4258EUR$4,850USD£3,724GBP
- Report
- February 2026
- 150 Pages
United States
From €3380EUR$3,850USD£2,956GBP
€4258EUR$4,850USD£3,724GBP
- Report
- February 2026
- 250 Pages
United States
From €3380EUR$3,850USD£2,956GBP
€4258EUR$4,850USD£3,724GBP
- Report
- February 2026
- 150 Pages
United States
From €3380EUR$3,850USD£2,956GBP
€4258EUR$4,850USD£3,724GBP
- Report
- February 2026
- 210 Pages
United States
From €3380EUR$3,850USD£2,956GBP
€4258EUR$4,850USD£3,724GBP
- Report
- February 2026
- 150 Pages
United States
From €3380EUR$3,850USD£2,956GBP
€4258EUR$4,850USD£3,724GBP
- Report
- February 2026
- 170 Pages
United States
From €3380EUR$3,850USD£2,956GBP
€4258EUR$4,850USD£3,724GBP
- Report
- February 2026
- 150 Pages
United States
From €3380EUR$3,850USD£2,956GBP
€4258EUR$4,850USD£3,724GBP
- Report
- February 2026
- 240 Pages
United States
From €3380EUR$3,850USD£2,956GBP
€4258EUR$4,850USD£3,724GBP
- Report
- February 2026
- 150 Pages
United States
From €3380EUR$3,850USD£2,956GBP
€4258EUR$4,850USD£3,724GBP
- Report
- December 2025
- 150 Pages
United States
From €3380EUR$3,850USD£2,956GBP
€4258EUR$4,850USD£3,724GBP
- Report
- December 2025
- 150 Pages
United States
From €3380EUR$3,850USD£2,956GBP
€4258EUR$4,850USD£3,724GBP
- Report
- February 2026
United States
From €3503EUR$3,990USD£3,064GBP

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more